When will Galenica report earnings and how should I use GALE.SW stock data?

Galenica's next earnings date is 10 Mar 2026. Use GALE.SW stock data to compare reported EPS to trailing EPS CHF3.86, watch revenue trends, and assess margin commentary for both Products & Care and Logistics & IT.

What is Meyka AI's price forecast for GALE.SW stock?

Meyka AI's forecast model projects CHF101.23 (1 month), CHF102.56 (quarter), and CHF108.62 (12 months). These imply a 12-month upside of about 16.04% from the current CHF93.60 price.

What are the main risks to a GALE.SW stock investment?

Primary risks include reimbursement changes, Swiss market concentration, margin pressure in distribution, and net debt to EBITDA around 2.34. Regulatory or reimbursement shocks could widen downside quickly.

How does Galenica's valuation compare within the Healthcare sector?

Galenica's PE is 24.37 versus the Healthcare sector average near 35.16. The lower PE suggests relative value, but investors should weigh this against growth rates and return on equity metrics.

CH Stocks

GALE.SW Galenica AG (SIX) 05 Mar 2026 intraday: CHF93.60 before earnings, model sees 16.04% upside

ByHuzaifa Zahoor March 5, 2026

GALE.SW stock trades intraday at CHF93.60 on the SIX exchange as we approach Galenica AG’s earnings release on 10 Mar 2026. Investors should watch margins, pharmacy sales, and Logistics & IT contract updates. The company reports trailing EPS CHF3.86 and a PE of 24.37, and volume is light at 27,491 shares today. This earnings spotlight focuses on metrics that can move the stock before and after the report